Roche Holding AG (OTCMKTS:RHHBY) Receives Average Recommendation of "Hold" from Analysts

Key Points

• Roche has an average “Hold” rating among 11 analysts: five recommend buying, five advise holding, and one recommends selling. The average 12-month price target is $60.00.
• Recent analyst actions were mixed: HSBC downgraded Roche to “Hold,” Zacks Research cut its view to “Strong Sell,” while Morgan Stanley upgraded the stock to “Overweight” with a $63.00 target.
• Roche shares opened at $58.10, near their 12-month high of $60.85, while several institutional investors recently initiated or increased positions in the company.

Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) has earned an average rating of "Hold" from the eleven ratings firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $60.00.

Several brokerages recently commented on RHHBY. HSBC downgraded Roche from a "buy" rating to a "hold" rating in a research note on Monday, July 6th. Zacks Research cut Roche from a "hold" rating to a "strong sell" rating in a research note on Tuesday, July 14th. Finally, Morgan Stanley upgraded Roche from an "equal weight" rating to an "overweight" rating and set a $63.00 price target for the company in a report on Friday, August 7th.

Institutional Trading of Roche

A number of large investors have recently bought and sold shares of RHHBY. Opal Capital LLC bought a new stake in shares of Roche in the first quarter worth $4,448,000. S&CO Inc. boosted its holdings in Roche by 163.0% during the first quarter. S&CO Inc. now owns 140,551 shares of the company's stock worth $6,880,000 after purchasing an additional 87,107 shares during the last quarter. Hantz Financial Services Inc. grew its position in Roche by 164.9% in the fourth quarter. Hantz Financial Services Inc. now owns 79,732 shares of the company's stock valued at $4,112,000 after purchasing an additional 49,633 shares in the last quarter. North Star Asset Management Inc. acquired a new stake in Roche in the 2nd quarter valued at $1,351,000. Finally, Puzo Michael J acquired a new stake in Roche in the 2nd quarter valued at $1,229,000.

Roche Price Performance

Shares of OTCMKTS RHHBY opened at $58.10 on Monday. Roche has a twelve month low of $39.50 and a twelve month high of $60.85. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.38 and a quick ratio of 1.12. The company's fifty day moving average is $53.30 and its 200-day moving average is $52.93.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY OTCMKTS: RHHBY.

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.